Typhoid Antibody Testing Market Size & Share, by Product Type {WIDAL Test, Typhidot Test, Rapid Serological Tests (Counter Immunoelectrophoresis, Hem-agglutination & Co-agglutination)}; End-user (Serological Testing Centers, Hospitals, Diagnostic Centers, Clinics, Other Healthcare Facilities) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4164
  • Published Date: Aug 10, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Typhoid Antibody Testing Market size is estimated to cross USD 12 Billion by the end of 2035, growing at a CAGR of 7% during the forecast period, i.e., 2023 – 2035. In the year 2022, the industry size of typhoid antibody testing was over USD 1 Billion. The market is estimated to grow on the back of a rapid increase in typhoid cases globally as an instance of poor sanitation practices. According to the report by the World Health Organization (WHO), by 2030, 1.6 billion people around the world are estimated to lack proper safe drinking water and 2.8 billion people are expected to be not able to attain safe sanitation services. Also in Asia Pacific, more than 4 million cases are diagnosed with typhoid every year due to improper sanitation practices.  

The global typhoid antibody testing market is also estimated to witness growth owing to the rising government efforts to make people aware of typhoid, develop nursing facilities, and manage the number of cases in their respective regions.

Typhoid Antibody Testing Market
Get more information on this report: Request Free Sample PDF

Typhoid Antibody Testing Sector: Growth Drivers and Challenges

Growth Drivers

  • Increased Rate of Morbidity and Mortality – Typhoid is a deadly disease that can kill people at the same time a wide number of people get affected by it.  According to the data from the World Health Organization (WHO), around 11 – 20 million people are known to have typhoid disease. In this, between 128,000 and 161,000 people are known to die as a result of the disease every year.
  • Government Support to Manage Typhoid Cases – Government authorities in developing countries are supporting initiatives that promote proper sanitization. Developing countries or underdeveloped countries don’t have proper sanitization. Government authorities of the regions have introduced various programs and initiatives for proper sanitization to support the management of typhoid cases.  For instance, the “Swachh Bharat Mission” program was initiated by the Indian government and aims to improve sanitation conditions and waste management, as well as the construction of community toilets throughout the country by 2019.
  • Increased Collaboration among the Market Players – Several companies have gone through mergers and acquisitions to expand their product portfolios and increase their market share. Growing merger collaboration among the market players is expected to drive the growth of the typhoid antibody testing market in the future. For instance, in 2020 Abbott Laboratories acquired Alere Inc.'s diagnostics business. This included a range of products to test for typhoid antibodies. 


  • Lacking Early Diagnosis of Enteric Symptoms – In 90% of cases it is seen that patients who are suffering from typhoid never get it diagnosed at an early age of symptoms. This is seen highly in Asia Pacific countries.
  • Lack of Awareness Related to Antibody Testing Kits
  • Patient’s Exposure to Other Antibiotics Before Visiting Healthcare Facility

Typhoid Antibody Testing Market: Key Insights

Base Year


Forecast Year

2023 - 2035



Base Year Market Size (2022)

~USD 1 Billion

Forecast Year Market Size (2035)

~ USD 12 Billion

Regional Synopsis

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Typhoid Antibody Testing Segmentation

End Users (Serological Testing Centers, Hospitals, Diagnostic Centers, Clinics, Other Healthcare Facilities)

The hospital segment in the typhoid antibody testing market is anticipated to garner the largest revenue share of 29% over the forecast period owing to the availability of proper medical facilities on hospital premises and the availability of advanced technologies and treatment. Besides this, the surge in the medical and tourism industry is also projected to generate numerous growth opportunities for the segment in the coming years. As per the Medical Tourism Association, about 14 million people in the world travel to other countries in search of medical care annually. Moreover, fast-paced, advanced technological equipment and people’s trust in a highly qualified professional are estimated to fuel the growth of the segment.

Product Type {WIDAL Test, Typhidot Test, Rapid Serological Tests (Counter Immunoelectrophoresis, Hem-agglutination & Co-agglutination)}

The WIDAL Test segment is projected to hold 40% share of the global typhoid antibody testing market in the forecast year. WIDAL test includes very fewer equipment and can be performed and learned easily. The WIDAL test is an advanced test that checks for antibodies in the body’s reaction to Salmonella typhi which is the core source of typhoid fever. It generally looks for O and H antibodies in the sample blood of patients. Therefore, owing to its advanced characteristics, this segment is expected to witness major growth over the upcoming decades.

Our in-depth analysis of the global typhoid antibody testing market includes the following segments:

        Product Type

  • WIDAL Test
  •  Typhidot Test
  • Rapid Serological Tests
    (Counter Immunoelectrophoresis,
    Hem-agglutination & Co-agglutination

        End Users

  • Serological Testing Centers
  • Hospitals
  • Diagnostic Centers,
  • Clinics
  • Other Healthcare Facilities

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Typhoid Antibody Testing Industry - Regional Synopsis

APAC Market Forecast

The typhoid antibody testing market in Asia Pacific is projected to hold the highest market share of 41% by the end of 2035. This is backed by the increase in typhoid cases in developing countries such as India, China, Bangladesh, Nepal, Vietnam, and Laos. These countries report more than 75% of typhoid cases around the world.

Moreover, various government-led initiatives aiming at managing the number of cases and spreading awareness and preventive measures are some factors that are expected to enhance the market growth in this region. For instance, in 2019, more than 450,000 typhoid cases have been found in Bangladesh, of which about 7,400 cases resulted in death.

European Market Statistics

The typhoid antibody testing market in Europe is poised to hold a significant market share of 29% by the end of 2025, owing to a highly developed healthcare infrastructure that includes fabulous levels of hygiene and sanitization facilities. They have proper personal hygiene products and public hygiene facilities, along with proper drinking water and food, owing to which a very low number of typhoid cases could be seen in this region. As per World Health Organization, Europe accounts for less than 500 cases of typhoid every year.

Research Nester
Typhoid Antibody Testing Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Typhoid Antibody Testing Market

    • IDL Biotech AB
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Medical Innovation Ventures Sdn Bhd
    • Thermo Fisher Scientific
    • Nectar Lifesciences Ltd.
    • DIALAB GmbH.
    • Siemens Healthcare GmbH
    • NanoEnTek
    • CerTest Biotec S.L.


In The News

  • IDL Biotech AB launched TUBEX TF, a rapid test for typhoid fever in Kenya. Launch took place at Kenya Medical Research Institute in the presence of doctors, pathologists, and representatives from the Ministry of Health.
  • BD launched a new automated cytometry system. The system enhances efficiency by reducing the chances of errors and reducing human intervention

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4164
  • Published Date: Aug 10, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Typhoid is on the rise in developing countries and increased competition among top competitors to produce fast and cost-effective diagnostic kits to diagnose typhoid cases is anticipated to boost the market growth.

The market is anticipated to attain a CAGR of 7% over the forecast period i.e., 2023 – 2035.

The market in Asia Pacific is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nuclear Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., and others.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Typhoid Antibody Testing Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying